Fundstrat added a new member to the firm's "Captain Ahab" CEO strategy.» Read More
Nearly 200 companies have reported earnings overnight and Thursday. Within that pack, it seems there's a disproportionate number of non-U.S. companies. In fact, by my calculations, there are 19 stocks from 11 different countries in my personal daily news mix...
In this installment of CNBC 101 — the investors' mini-seminar — learn the potential advantages of investing via municipal bond ETFs.
Consumer discretionary stocks are not only the worst performers today — and this week and this month — but 60 percent of the 18 discretionary stocks that reported earnings are down. So what is working in one of the worst groups right now?
Pharmaceuticals are priced at a bargain, said Mike Burnick, Weiss Capital Management director of research.
The problem for UPS may be in its Q4 guidance—don’t be surprised if it's lower than the roughly $0.96 expected due to expected lower volume.
Though it was another disappointing day, note that the Dow was down 690 points at 3:40 PM ET and then rallied 170 points into the close. The S&P 500 and the NASDAQ closed at new lows. Despite all the worries about redemptions and forced selling, volume was notably light until the last 45 minutes. It really was more of a buyers' strike as bids simply got cancelled.
Dan Gross, senior editor and columnist at Newsweek, says that a country’s number of Starbucks stores inversely correlates with its economic health—the more Starbucks stores, the greater the financial crisis.
Jeffrey Grundlach's bond fund is up 3.01 percent year-to-date. (Yes, you read correctly.) The chief investment officer of TCW offered his market outlook to CNBC.
Defense technology and defense information tech are two areas investors want to be in right now, according to Alex Hamilton, senior managing director at Jesup & Lamont.
Dan Genter, CIO at RNC Genter Capital Management, told CNBC that it is a good time for investors to put their money into the energy and financial sectors.
In an economic downturn, it’s time to take a long-term perspective, said Michael Cuggino, Permanent Portfolio Funds president.
Pharmaceutical stocks were winners today on the earnings front, and CNBC guests say they can be winners on the portfolio front as well.
This year the S&P Industrial Index fared even worse than the S&P 500, but Eli Lustgarten, senior vice president of Longbow Research, sees opportunities in this beaten-down sector.
Mid-cap stocks will be the next market movers, says Ron Sloan, senior portfolio manager at Aim Mid Cap Core Equity.
Linda Bolton-Weiser, managing director at Caris & Company, says consumer staples stocks are the way to go. She expects earnings growth to be relatively strong at "around 10 percent on average."
Diageo upgraded to "add" from "hold", "buy" recommendation for Carlsberg maintained and three pure champagne stocks for the future from Dresdner Kleinwort.
Although the health care industry is not immune to a sluggish economy, the sector presents some attractive opportunities, said Carl McDonald, a senior analyst at Oppenheimer & Co.
Investors will have a rough ride until April, says Bill Spiropoulos, CEO of CoreStates Capital Advisors, but he thinks now is the time to put money to work.
Some stocks are more popular than others. But that doesn't mean they're always the best shares to hold. Michael Farr, president of Farr, Miller and Washington, gave his assessment of five of the most widely held companies.
Consumer cyclicals such as retailers are becoming attractive, said Bob Stovall, Wood Asset Management managing director and global strategist.